ArticleFrontiers in oncology2026
Primary urethral clear cell carcinoma: a rare case report.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 59-year-old female patient was admitted due to a vaginal mass detected one month ago. There is no family history of malignant tumors, nor any relevant complications. One month prior, she incidentally palpated a cystic mass on the anterior vaginal wall while bathing. She reported no dysuria, hematuria, abdominal pain, or vaginal bleeding. Over the past week, she developed dysuria with interrupted urine flow, but no frequency or urgency. Pelvic MRI revealed a cystic-solid mass in the anterior vaginal wall with indistinct borders from the urethra. Needle biopsy of the vaginal mass combined with immunohistochemistry initially suggested clear cell adenocarcinoma. Final diagnosis was confirmed as primary urethral clear cell carcinoma by pathological examination of the radical resection specimen. Cystic masses in the anterior vaginal wall should raise suspicion for urothelial origin clear cell carcinoma. Fine-needle aspiration biopsy combined with immunohistochemistry may still yield misdiagnosis; definitive diagnosis relies on pathological examination of resected specimens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.